DE602007011923D1 - Hepatocytenwachstumsfaktor-(hgf-)bindungsproteine - Google Patents
Hepatocytenwachstumsfaktor-(hgf-)bindungsproteineInfo
- Publication number
- DE602007011923D1 DE602007011923D1 DE602007011923T DE602007011923T DE602007011923D1 DE 602007011923 D1 DE602007011923 D1 DE 602007011923D1 DE 602007011923 T DE602007011923 T DE 602007011923T DE 602007011923 T DE602007011923 T DE 602007011923T DE 602007011923 D1 DE602007011923 D1 DE 602007011923D1
- Authority
- DE
- Germany
- Prior art keywords
- hepatocytenwachstumsfaktor
- hgf
- binding proteins
- proteins
- binding
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/565—Complementarity determining region [CDR]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
- C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Crystals, And After-Treatments Of Crystals (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US81071406P | 2006-06-02 | 2006-06-02 | |
US86050906P | 2006-11-21 | 2006-11-21 | |
PCT/US2007/012939 WO2007143090A2 (en) | 2006-06-02 | 2007-06-01 | Hepatocyte growth factor (hgf) binding proteins |
Publications (1)
Publication Number | Publication Date |
---|---|
DE602007011923D1 true DE602007011923D1 (de) | 2011-02-24 |
Family
ID=38802077
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE602007011923T Active DE602007011923D1 (de) | 2006-06-02 | 2007-06-01 | Hepatocytenwachstumsfaktor-(hgf-)bindungsproteine |
Country Status (21)
Country | Link |
---|---|
US (5) | US7649083B2 (de) |
EP (2) | EP2361934A3 (de) |
JP (3) | JP4686634B2 (de) |
KR (1) | KR101196060B1 (de) |
AR (1) | AR061171A1 (de) |
AT (1) | ATE495195T1 (de) |
AU (1) | AU2007254942B2 (de) |
BR (1) | BRPI0712222B1 (de) |
CA (1) | CA2654025C (de) |
CY (1) | CY1111714T1 (de) |
DE (1) | DE602007011923D1 (de) |
DK (1) | DK2027156T3 (de) |
HK (1) | HK1129395A1 (de) |
IL (2) | IL195037A (de) |
MX (1) | MX2008014829A (de) |
NO (1) | NO345476B1 (de) |
NZ (1) | NZ573818A (de) |
PL (1) | PL2027156T3 (de) |
PT (1) | PT2027156E (de) |
SG (1) | SG158112A1 (de) |
WO (1) | WO2007143090A2 (de) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103880955A (zh) | 2003-07-18 | 2014-06-25 | 安姆根有限公司 | 肝细胞生长因子的特异性结合物 |
MX2008015138A (es) * | 2006-06-02 | 2009-01-28 | Aveo Pharmaceuticals Inc | Proteinas de union al factor de crecimiento de hepatocitos (fch). |
NO345476B1 (no) * | 2006-06-02 | 2021-02-22 | Xoma Technology Ltd | Bindingsproteiner for hepatocyttvekstfaktor (HGF) |
US20080233660A1 (en) * | 2007-03-23 | 2008-09-25 | Mu Bioteknik Ab | Solid phase labeling method |
SI2173379T1 (sl) | 2007-07-02 | 2015-12-31 | Oncomed Pharmaceuticals, Inc. | Sestavki in postopki za zdravljenje in diagnosticiranje raka |
EP2220117A2 (de) | 2007-11-30 | 2010-08-25 | Kalobios Pharmaceuticals, Inc. | Antikörper gegen das pcrv-antigen von pseudomonas aeruginosa |
HUE046037T2 (hu) * | 2008-03-14 | 2020-01-28 | Allergan Inc | Immun-alapú, A szerotípusú botulinum toxin aktivitás vizsgálati eljárások |
WO2009148928A1 (en) | 2008-05-29 | 2009-12-10 | Galaxy Biotech, Llc | Monoclonal antibodies to basic fibroblast growth factor |
NO2842573T3 (de) | 2008-11-07 | 2018-02-24 | ||
WO2010119991A2 (en) | 2009-04-17 | 2010-10-21 | Takeda Pharmaceutical Company Limited | Novel method of treating cancer |
JP2013532627A (ja) | 2010-07-01 | 2013-08-19 | 武田薬品工業株式会社 | cMET阻害剤とHGFおよび/またはcMETに対する抗体との組み合わせ |
AU2011295919A1 (en) | 2010-08-31 | 2013-03-07 | Genentech, Inc. | Biomarkers and methods of treatment |
US9217040B2 (en) | 2011-01-14 | 2015-12-22 | The Regents Of The University Of California | Therapeutic antibodies against ROR-1 protein and methods for use of same |
US8802097B2 (en) | 2011-07-15 | 2014-08-12 | Oncomed Pharmaceuticals, Inc. | Anti-RSPO1 antibodies |
WO2013036872A1 (en) | 2011-09-09 | 2013-03-14 | Amgen Inc. | Use of c-met protein for predicting the efficacy of anti-hepatocyte growth factor ("hgf") antibodies in esophageal and gastric cancer patients |
AR087918A1 (es) | 2011-09-19 | 2014-04-23 | Genentech Inc | Tratamientos combinados que comprenden antagonistas de c-met y antagonistas de b-raf |
WO2014012007A2 (en) | 2012-07-13 | 2014-01-16 | Oncomed Pharmaceuticals, Inc. | Rspo3 binding agents and uses thereof |
BR112015018418A2 (pt) | 2013-02-22 | 2017-07-18 | Hoffmann La Roche | métodos para tratar câncer, para aumentar a eficácia de um tratamento, para adiar e/ou prevenir o desenvolvimento de câncer, para aumentar a sensibilidade a um terapêutico direcionado, para estender o período de sensibilidade, para estender a duração de resposta a um terapêutico direcionado e produto farmacêutico |
US9062104B2 (en) * | 2013-03-14 | 2015-06-23 | Alderbio Holdings Llc | Therapeutic use of antibodies to HGF |
US9481725B2 (en) * | 2013-03-14 | 2016-11-01 | Alderbio Holdings, Llc | Antibodies to HGF and compositions containing |
US9732150B2 (en) * | 2013-03-14 | 2017-08-15 | Alderbio Holdings Llc | Therapeutic use of antibodies to HGF |
TW201444868A (zh) * | 2013-03-14 | 2014-12-01 | Alder Biopharmaceuticals Inc | Hgf抗體及其組成物 |
WO2014166029A1 (zh) * | 2013-04-07 | 2014-10-16 | 永卓博济(上海)生物医药技术有限公司 | 针对表皮生长因子受体的抗体 |
WO2015031578A1 (en) * | 2013-08-28 | 2015-03-05 | Abbvie Inc. | Hgf assay |
RU2016141385A (ru) | 2014-03-24 | 2018-04-28 | Дженентек, Инк. | Лечение рака антагонистами с-мет и их корреляция с экспрессией hgf |
JP2017524371A (ja) | 2014-05-23 | 2017-08-31 | ジェネンテック, インコーポレイテッド | Mitバイオマーカーとその使用方法 |
JP2017526356A (ja) * | 2014-08-15 | 2017-09-14 | オンコメッド ファーマシューティカルズ インコーポレイテッド | Rspo1結合剤およびその使用 |
CA2961374A1 (en) | 2014-09-16 | 2016-03-24 | Oncomed Pharmaceuticals, Inc. | Treatment of fibrotic diseases |
WO2017070567A1 (en) * | 2015-10-21 | 2017-04-27 | The Research Foundation For The State University Of New York | Klebsiella pneumoniae antibodies and methods to treat klebsiella pneumoniae infections |
CA3148713A1 (en) | 2019-08-12 | 2021-02-18 | Interna Technologies B.V. | New treatments involving mirna-193a |
EP4110917A1 (de) | 2020-02-28 | 2023-01-04 | InteRNA Technologies B.V. | Mirna-193a zur förderung des immunogenen zelltods |
JP2023539581A (ja) * | 2020-08-28 | 2023-09-15 | 江蘇恒瑞医薬股▲ふん▼有限公司 | ヘテロポリペプチドの末端異質性を低減するためのシグナルペプチド |
Family Cites Families (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
US6548640B1 (en) | 1986-03-27 | 2003-04-15 | Btg International Limited | Altered antibodies |
US6893625B1 (en) | 1986-10-27 | 2005-05-17 | Royalty Pharma Finance Trust | Chimeric antibody with specificity to human B cell surface antigen |
IL85035A0 (en) | 1987-01-08 | 1988-06-30 | Int Genetic Eng | Polynucleotide molecule,a chimeric antibody with specificity for human b cell surface antigen,a process for the preparation and methods utilizing the same |
US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
US5859205A (en) | 1989-12-21 | 1999-01-12 | Celltech Limited | Humanised antibodies |
WO1994004679A1 (en) | 1991-06-14 | 1994-03-03 | Genentech, Inc. | Method for making humanized antibodies |
US5565332A (en) | 1991-09-23 | 1996-10-15 | Medical Research Council | Production of chimeric antibodies - a combinatorial approach |
US5869619A (en) | 1991-12-13 | 1999-02-09 | Xoma Corporation | Modified antibody variable domains |
JP4157160B2 (ja) * | 1991-12-13 | 2008-09-24 | ゾーマ テクノロジー リミテッド | 改変抗体可変領域の調製のための方法 |
CA2129663C (en) | 1992-02-06 | 2005-07-05 | James S. Huston | Biosynthetic binding protein for cancer marker |
US5639641A (en) | 1992-09-09 | 1997-06-17 | Immunogen Inc. | Resurfacing of rodent antibodies |
US6066718A (en) | 1992-09-25 | 2000-05-23 | Novartis Corporation | Reshaped monoclonal antibodies against an immunoglobulin isotype |
US5837676A (en) | 1993-10-18 | 1998-11-17 | Long Island Jewish Medical Center | Use of scatter factor to enhance angiogenesis |
US6498144B1 (en) * | 1993-10-18 | 2002-12-24 | North Shore - Long Island Jewish Research Institute | Use of scatter factor to enhance angiogenesis |
US5707624A (en) | 1994-06-03 | 1998-01-13 | The Regents Of The University Of Michigan | Treatment of Kaposi's sarcoma by inhibition of scatter factor |
EP2314625B1 (de) | 1996-12-03 | 2014-05-07 | Amgen Fremont Inc. | Transgene Säugetiere, die menschliche Ig-loci einschliesslich mehrere VH und Vkappa Regionen enthalten, und davon erhaltene Antikörper |
US6872518B2 (en) | 1997-09-22 | 2005-03-29 | University Of Rochester | Methods for selecting polynucleotides encoding T cell epitopes |
US7459536B1 (en) | 1999-11-09 | 2008-12-02 | The United States Of America As Represented By The Secretary, Department Of Health And Human Services | HGF-SF monoclonal antibody combinations |
EP2298809A3 (de) | 2001-07-12 | 2012-02-15 | FOOTE, Jefferson | Superhumanisierter Antikörper |
US20040208876A1 (en) | 2003-04-18 | 2004-10-21 | Kim Kyung Jin | Monoclonal antibodies to hepatocyte growth factor |
US7220410B2 (en) * | 2003-04-18 | 2007-05-22 | Galaxy Biotech, Llc | Monoclonal antibodies to hepatocyte growth factor |
CN103880955A (zh) | 2003-07-18 | 2014-06-25 | 安姆根有限公司 | 肝细胞生长因子的特异性结合物 |
KR100556660B1 (ko) | 2003-11-11 | 2006-03-10 | 국립암센터 | Hgf의 중화가능 에피토프 및 이에 결합하는 중화 항체 |
CA2607699A1 (en) | 2005-06-02 | 2006-12-07 | Galaxy Biotech, Llc | Methods of treating brain tumors with antibodies |
AR059922A1 (es) | 2006-04-01 | 2008-05-07 | Galaxy Biotech Llc | Anticuerpos monoclonales humanizados para el factor de crecimiento de hepatocitos |
MX2008015138A (es) | 2006-06-02 | 2009-01-28 | Aveo Pharmaceuticals Inc | Proteinas de union al factor de crecimiento de hepatocitos (fch). |
NO345476B1 (no) | 2006-06-02 | 2021-02-22 | Xoma Technology Ltd | Bindingsproteiner for hepatocyttvekstfaktor (HGF) |
KR100829972B1 (ko) * | 2006-07-14 | 2008-05-16 | 재단법인서울대학교산학협력재단 | 항-hgf/sf 인간화 항체 및 이의 제조방법 |
KR100881825B1 (ko) * | 2007-07-27 | 2009-02-03 | 주식회사 하이닉스반도체 | 반도체 소자 및 그 제조 방법 |
-
2007
- 2007-06-01 NO NO20085421A patent/NO345476B1/no not_active Application Discontinuation
- 2007-06-01 NZ NZ573818A patent/NZ573818A/en unknown
- 2007-06-01 EP EP11150489A patent/EP2361934A3/de not_active Withdrawn
- 2007-06-01 DK DK07795599.5T patent/DK2027156T3/da active
- 2007-06-01 SG SG200908089-6A patent/SG158112A1/en unknown
- 2007-06-01 AT AT07795599T patent/ATE495195T1/de active
- 2007-06-01 CA CA2654025A patent/CA2654025C/en active Active
- 2007-06-01 BR BRPI0712222-5A patent/BRPI0712222B1/pt active IP Right Grant
- 2007-06-01 KR KR1020087032083A patent/KR101196060B1/ko active IP Right Grant
- 2007-06-01 EP EP07795599A patent/EP2027156B9/de active Active
- 2007-06-01 PL PL07795599T patent/PL2027156T3/pl unknown
- 2007-06-01 AU AU2007254942A patent/AU2007254942B2/en active Active
- 2007-06-01 US US11/757,059 patent/US7649083B2/en active Active
- 2007-06-01 PT PT07795599T patent/PT2027156E/pt unknown
- 2007-06-01 AR ARP070102389A patent/AR061171A1/es active IP Right Grant
- 2007-06-01 JP JP2009513295A patent/JP4686634B2/ja active Active
- 2007-06-01 DE DE602007011923T patent/DE602007011923D1/de active Active
- 2007-06-01 MX MX2008014829A patent/MX2008014829A/es active IP Right Grant
- 2007-06-01 WO PCT/US2007/012939 patent/WO2007143090A2/en active Application Filing
-
2008
- 2008-11-02 IL IL195037A patent/IL195037A/en active IP Right Grant
-
2009
- 2009-08-13 HK HK09107470.5A patent/HK1129395A1/xx unknown
- 2009-12-07 US US12/632,765 patent/US7943344B2/en active Active
-
2010
- 2010-12-28 JP JP2010294222A patent/JP2011072318A/ja not_active Withdrawn
-
2011
- 2011-03-18 US US13/051,481 patent/US8273355B2/en active Active
- 2011-04-11 CY CY20111100371T patent/CY1111714T1/el unknown
-
2012
- 2012-05-08 IL IL219654A patent/IL219654A0/en unknown
- 2012-08-20 US US13/589,664 patent/US8580930B2/en active Active
- 2012-12-10 JP JP2012269474A patent/JP5735476B2/ja active Active
-
2013
- 2013-10-02 US US14/044,278 patent/US9096664B2/en active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY2020009I1 (el) | Δεσμευτικοι παραγοντες σκληροστινης | |
DE602007011923D1 (de) | Hepatocytenwachstumsfaktor-(hgf-)bindungsproteine | |
DK2046826T3 (da) | Exendin-fusionsproteiner | |
DK3339445T3 (da) | Interleukin -13 bindende proteiner | |
DK3118221T3 (da) | Proteiner | |
DK1776383T3 (da) | Bindingsmolekyler | |
DK1999154T3 (da) | Fremstillede heterodimere proteindomæner | |
DK2094292T3 (da) | Salpeteroxid-blokeret tværbundet tetramerisk hæmoglobin | |
DK2194043T3 (da) | Fremgangsmåder | |
DK1888113T3 (da) | Tweak-bindende antistoffer | |
BRPI0814971A2 (pt) | Proteína | |
DE602006012066D1 (de) | Daraus | |
DK1885966T3 (da) | Forbedret hoved-t-forbindelse | |
DK1809660T3 (da) | Thymus-specifikt protein | |
DE502005004418D1 (de) | Turbolader | |
DK2081952T3 (da) | Peptider | |
FI20050547A0 (fi) | Side | |
DK2219663T3 (da) | Revers-protein | |
AT504183A3 (de) | Skibindungssystem | |
FI20041026A0 (fi) | Sidontalaite | |
ITCN20060002A1 (it) | Imbiellaggio martino | |
FI20050349A0 (fi) | Sidontalaite | |
FI20050927A0 (fi) | Sidontalaite | |
FI20050718A0 (fi) | Sidontalaite | |
FI20050009A0 (fi) | Sidontalaite |